Agilon Health (NYSE:AGL) Stock Price Down 9.5% – Here’s Why

Agilon Health, Inc. (NYSE:AGL – Get Free Report)’s share price was down 9.5% on Wednesday. The company traded as low as $104.06 and last traded at $104.2770. 27,812 shares changed hands during mid-day trading, a decline of 91% from the average daily volume of 314,814 shares. The stock had previously closed at $115.20.

Analysts Set New Price Targets

Several research firms recently weighed in on AGL. Zacks Research raised Agilon Health from a “hold” rating to a “strong-buy” rating in a report on Friday, November 13th. StoneX upped their price objective on shares of Agilon Health from $140.00 to $145.00 and gave the stock a “buy” rating in a report on Wednesday, November 11th. Wells Fargo & Company raised their target price on shares of Agilon Health from $146.00 to $170.00 and gave the stock an “overweight” rating in a research note on Friday, November 13th. Truist Financial set a $112.00 price target on shares of Agilon Health and gave the company a “hold” rating in a research report on Thursday, August 6th. Finally, Barclays set a $111.00 price target on shares of Agilon Health and gave the stock an “equal weight” rating in a research note on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Agilon Health currently has an average rating of “Hold” and a consensus price target of $108.38.

Check Out Our Latest Analysis on AGL

Agilon Health Stock Down 1.1%

The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.06. The firm has a 50-day moving average of $91.64 and a two-hundred day moving average of $70.63. The firm has a market cap of $1.50 billion, a price-to-earnings ratio of -16.14 and a beta of 3.10.

Agilon Health (NYSE:AGL – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $1.97 EPS for the quarter, topping analysts’ consensus estimates of ($1.23) by $3.20. The firm had revenue of $1.52 billion during the quarter, compared to analysts’ expectations of $1.46 billion. Agilon Health had a negative net margin of 1.45% and a negative return on equity of 51.97%. As a group, sell-side analysts predict that Agilon Health, Inc. will post -1.87 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Sterling Capital Management LLC bought a new position in Agilon Health in the third quarter valued at approximately $33,000. Root Financial Partners LLC acquired a new stake in shares of Agilon Health in the third quarter valued at about $57,000. State of Alaska Department of Revenue bought a new stake in Agilon Health in the third quarter valued at $64,000. Allworth Financial LP purchased a new position in shares of Agilon Health during the second quarter valued at approximately $114,000. Finally, Proficio Capital Partners LLC bought a new position in Agilon Health during the second quarter valued at about $210,000.

About Agilon Health

(Get Free Report)

Agilon Health is a U.S. healthcare company that partners with primary care physicians to provide care for patients enrolled in Medicare Advantage plans. Its model is designed to help physician groups move from traditional fee-for-service care toward value-based care, in which providers are rewarded for improving patients’ health and coordinating their care. The company provides participating physician groups with clinical, operational, technology and administrative support, along with resources to manage patient populations and coordinate care across local healthcare networks.

See Also

Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.